Philip Morris CEO: IQOS Holds 80% of Japan's Heated Tobacco Market, Growth Expected for Next Decade

Mar.17.2025
Philip Morris CEO: IQOS Holds 80% of Japan's Heated Tobacco Market, Growth Expected for Next Decade
CEO of Philip Morris International (PMI) indicates strong growth for IQOS in Japan despite pending tax hike.

Key points:

 

1. Philip Morris International (PMI) CEO Jacek Olczak stated that "IQOS" holds an 80% market share in Japan, with nearly 50% of smokers using the product. He expects the market to continue growing in the next ten years.

 

2. Japan plans to raise the tax rate on heated tobacco products to be equal to traditional cigarettes by 2026, with further increases scheduled for 2027. Olczak suggests that this policy may have a negative impact on consumers who have already switched to heated tobacco products.

 

3. Olczak said that heating tobacco can reduce the risk of exposing harmful ingredients by 90% to 95%, and existing data is sufficient to prove its positive impact.

 


 

2Firsts, reporting from Shenzhen - According to a report by Sankei on March 17, Jacek Olczak, the CEO of Philip Morris International (PMI), stated in an interview with Sankei that PMI's heated tobacco product, "IQOS", first launched in Japan 12 years ago, currently holds a market share of approximately 80% in the country.

 

Olsak pointed out that the use of heated tobacco among smokers in Japan is close to 50%, and the trend of shifting from traditional cigarettes to heated tobacco remains very active. He believes that the heated tobacco market will continue to grow over the next decade.

 

In addition, the Japanese government is planning to increase the tax rate on heated tobacco products to the same level as traditional cigarettes by 2026, and to continue raising taxes in 2027. 

 

This policy has raised concerns from PMI. Olczak pointed out that heated tobacco products are considered to pose lower health risks than traditional cigarettes, and in some countries in Europe and the Americas, governments encourage smokers to switch from traditional cigarettes to heated tobacco products through tax incentives. 

 

He believes that the government's tax increase policy in Japan may have a negative impact on consumers who have already switched to heated tobacco products, even "punishing" them for making a healthier choice.

 

During the interview, Olczak also elaborated on the current situation and prospects of heated tobacco in the Japanese market. 

 

He pointed out that heated tobacco maintains a double-digit annual growth rate in many markets globally, and Japan is transitioning from traditional cigarettes to heated tobacco at a faster pace than other countries. 

 

Currently, in ten major cities such as Tokyo, Sendai, and Fukuoka, the market share of heated tobacco has exceeded that of traditional cigarettes.

 

Despite facing challenges such as a decreasing population and shrinking market size, Olczak remains confident in the market outlook for heated tobacco products in Japan. 

 

He pointed out that since the introduction of heated tobacco products, nearly half of smokers have switched from traditional cigarettes. It is expected that the remaining smokers will take at least another 10 years to complete this transition, indicating that there is still significant growth potential in the market.

 

Regarding the Japanese government's policy of raising the tobacco tax rate to enhance national defense capabilities, Olczak said that from a global perspective of "Harm Reduction," many countries are promoting a shift from traditional tobacco to heated tobacco through taxation and regulation policies. 

 

He believes that the Japanese government should support consumers who have already made better choices, rather than hindering this process by increasing tax rates.

 

Olczak also responded to concerns about the lack of long-term clinical data on the health risks of heated tobacco. 

 

He pointed out that PMI has conducted studies showing that heated tobacco can reduce smokers' exposure to harmful components found in traditional cigarettes by 90% to 95%. 

 

He believes that even without long-term epidemiological clinical results, the current data alone is sufficient to anticipate the positive impact of heated tobacco. He questioned whether it is reasonable to allow smokers to continue to bear the health risks associated with traditional cigarettes simply because of a lack of data.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21
UK Vape Tax Countdown: Retailer Vape HQ Estimates 100ml E-liquid Prices Could Rise From £12.99 to £39.39, While Pod Kits Increase Less Than 10%
UK Vape Tax Countdown: Retailer Vape HQ Estimates 100ml E-liquid Prices Could Rise From £12.99 to £39.39, While Pod Kits Increase Less Than 10%
The UK’s Vaping Products Duty (VPD), scheduled to take effect in October 2026, is prompting retailers to assess how different vape categories may be affected. UK retailer Vape HQ has estimated potential price changes under the new volume-based tax system, showing that 100ml shortfill e-liquids could see prices rise from around £12.99 to £39.39, a 203% increase, while 2ml prefilled pod vape kits could rise from £5.99 to £6.52, an increase of about 9%. The estimates highlight how a volume-based tax structure creates uneven cost impacts across product categories.
Aug.19
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
According to recent LinkedIn posts from people at VAPORESSO, SMOORE and a German distribution partner, vape brand DOJO will begin rolling out a new global brand identity on September 1, 2026, led by a redesigned handwritten logo. The new visual system will be gradually applied across product packaging, marketing materials and digital assets over the following months. Fabio Corsaro, Head of Marketing and Purchasing at MG Wesel GmbH, said the rebrand was related to trademark issues, but that explanation has not been publicly confirmed by DOJO, VAPORESSO or SMOORE. DOJO is currently promoting its Blast X product in Germany.
Aug.31
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27